| 摘要 |
<p>A new pharmaceutical use of 2-chloro-11-(2-dimethylaminoethoxy)dibenzo(b,f) thiepin or its pharmaceutically acceptable salt for lowering uric acid, a pharmaceutical composition comprising a pharmaceutical uric acid-lowering composition comprising 2-chloro-11-(2-dimethylaminoethoxy) dbenzo-(b,f) thiepin or its pharmaceutically acceptable salt in association with a pharmaceutically acceptable, substantially non-toxic carrier or excipient, and a method for preventing and/or treating gout. </p> |
